Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Global Survey of Trilateral Retinoblastoma: Incidence and Outcomes

NCT06367530 is registered in ClinicalTrials.gov with Amsterdam UMC, location VUmc as lead sponsor.

NCT NCT06367530
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06367530 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Global Survey of Trilateral Retinoblastoma: Incidence and Outcomes
Lead sponsor
Amsterdam UMC, location VUmc
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2024
Completion date
December 31, 2029
Enrollment
4,351 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

retinoblastoma, trilateral retinoblastoma